Progyny, Inc.

Progyny, Inc. (PGNY) priced its initial public offering on Oct 25, 2019 at $13.00 per share, below its $14.00–$16.00 range, raising $130M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $1.07B. J.P. Morgan was lead-left underwriter, joined by Goldman Sachs, BofA Securities and Citigroup and others. Cooley advised the company and Davis Polk advised the underwriters.

Progyny, Inc. is a benefits management company specializing in fertility and family building benefits in the United States. It works with employers, with over 80 clients, to cover employees and their partners and to guide them to treatment from physicians in its network.

Status

IPO

Ticker

PGNY

Exchange

Nasdaq Global Select

Priced

Oct 25, 2019

IPO price

$13.00

Price range

$14.00–$16.00

Raised

$130M

Market cap at IPO price

$1.07B

First filed

Sep 27, 2019

Underwriters

J.P. Morgan, Goldman Sachs, BofA Securities, Citigroup and Leerink Partners

Company counsel

Cooley

Underwriters' counsel

Davis Polk

Sector

Healthcare

Country / state

NY

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.